![]() Our biolayer interferometry immunosorbent assay (BLI-ISA) utilizes single-use biosensors in an automated “dip-and-read” format, providing real-time optical measurements of antigen loading, plasma antibody binding, and antibody isotype detection. Here, we describe a novel application of biolayer interferometry for the rapid detection of antigen-specific antibody levels in plasma samples, and demonstrate its utility for quantification of SARS-CoV-2 antibodies. The company is powered by Ortho Care ™, an award-winning, holistic service and support program that ensures best-in-class technical, field and remote service and inventory support to laboratories in more than 130 countries and territories around the globe.įor more information, visit Ortho's website or social media channels: LinkedIn, Twitter, Facebook and YouTube.Serological testing to evaluate antigen-specific antibodies in plasma is generally performed by rapid lateral flow test strips that lack quantitative results or by high complexity immunoassays that are time- and labor-intensive but provide semi-quantitative results. Food and Drug Administration-authorized high-volume antibody and antigen tests for COVID-19, Ortho has been a pioneering leader in the IVD space for over 80 years. Ortho's customized solutions enhance clinical outcomes, improve efficiency, overcome lab staffing challenges and reduce costs.įrom launching the first product to determine Rh+ or Rh- blood type, developing the world's first tests for the detection of antibodies against HIV and hepatitis C, introducing patented dry-slide technology and marketing the first U.S. Because Every Test is a Life ™, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to ensure test results are fast, accurate, and reliable. More than 800,000 patients across the world are impacted by Ortho's tests each day. Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world's largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care. ![]() The assays run on Ortho's high-throughput, fully automated analyzers including its flagship VITROS® XT 7600 Integrated System, the VITROS® 3600 Immunodiagnostic System, the VITROS® 5600 Integrated System and VITROS® ECi/ECiQ Immunodiagnostic Systems. "As a trusted partner to our customers from the beginning of this pandemic, Ortho will continue to bring to market solutions that help them quickly provide critical results to clinicians while keeping their lab running as efficiently as possible." "Across the world, there continues to be a great need for COVID-19 testing-to understand if a person is infected, how they are responding to treatment or a vaccine, or to help assess the spread of the disease," said Chockalingam Palaniappan, PhD, chief innovation officer, Ortho Clinical Diagnostics. The tests can also be used to assess titers of neutralizing antibodies –which are responsible for protective immune response-and can be used to identify plasma suitable for convalescent plasma therapy. ![]() With both assays showing 100% specificity i and excellent sensitivity, ii Ortho's new COVID-19 Total 2 and IgG 2 antibody assays help clinicians understand each patient's adaptive immune response (acquired naturally post-infection or through vaccination) to SARS-CoV-2. In addition to generating a positive (reactive) or negative (non-reactive) result, Ortho's Total 2 and IgG 2 antibody assays offer a measurement value of SARS-CoV-2 antibodies with easy-to-read results that eliminate the need for repeat testing and improve lab workflow. ![]() RARITAN, N.J., Ma/PRNewswire/ - Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play IVD companies dedicated to transforming patient care, today announced that its new VITROS ® Anti-SARS-CoV-2 Total 2 Antibody assay and VITROS ® Anti-SARS-CoV-2 IgG 2 Antibody assay received CE Mark for the qualitative and semi-quantitative detection of COVID-19 antibodies. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |